This is a preview of subscription content, log in via an institution to check access.
Notes
high-mobility group AT-hook 2
Reference
Tremblay G, et al. Cost-Effectiveness Analysis of a HMGA2 Prognostic Test for Acute Myeloid Leukemia in a Canadian Setting. Applied Health Economics and Health Policy : 7 Aug 2019. Available from: URL: https://doi.org/10.1007/s40258-019-00503-5
Rights and permissions
About this article
Cite this article
New prognostic test for AML improves outcomes, reduces cost. PharmacoEcon Outcomes News 835, 21 (2019). https://doi.org/10.1007/s40274-019-6158-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-6158-1